Royalty Pharma plc
RPRX
Rank in Stocks
#894
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Share Price
$60.39
Last synced: 2026-10-19
Market Cap
$26.89B
Change (1 day)
-0.93%
Change (1 year)
64.87%
Country
US
Trade Royalty Pharma plc (RPRX)
Category
Healthcare
Dividend yield history for Royalty Pharma plc (RPRX)
Royalty Pharma plc (stock symbol: RPRX) dividend yield (TTM) as of 2023-12-31: 2.85%
Average dividend yield, last 5 years : 2.37%
Average dividend yield, last 5 years : 2.37%
Dividend yield history for Royalty Pharma plc (RPRX) from 2015 to 2026
Dividend Yield at the end of each year (TTM)
| Year | Dividend Yield | Change |
|---|---|---|
| 2026 (TTM) | 1.57% | -52.57% |
| 2024 | 3.31% | 16.14% |
| 2023 | 2.85% | 47.67% |
| 2022 | 1.93% | 11.56% |
| 2021 | 1.73% | -15.61% |
| 2020 | 2.05% | -56.29% |
| 2019 | 4.69% | -9.28% |
| 2018 | 5.17% | 10.94% |
| 2017 | 4.66% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
Dividend yields (TTM) for similar companies or competitors
| Company | Dividend Yield | Country |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 0.00% |
US
|
|
| 2.29% |
HK
|
